A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Clinical trial NCT05757869 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05757869
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-11
- Primary completion
- 2026-10-31
- Enrollment
- 20284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.